2025-03-24 12:28:01
Latest Post
NIIT Limited offers gNIIT, a customizable dual qualification program for undergraduate students
TVS Holdings Limited declares interim dividend of Rs. 93- Roni Households Limited allots 57,46,546 bonus shares
Pasupati Acrylon Limited commissions 150 KL Ethanol Plant
SBC Exports Ltd receives repeat Export Order, ties up with Day-to-Day retail chain
Stock Report
Nath Bio-Genes India Ltd Q3 FY25 consolidated profit increases QoQ to Rs. 2.65 crore
Posted On : 2025-01-24 09:32:30( TIMEZONE : IST )
Nath Bio-Genes (India) Limited has reported Consolidated financial results for the period ended December 31, 2024.
Financial Results (Q3 FY2025) - QoQ Comparison
The company has reported total income of Rs. 36.8728 crores during the period ended December 31, 2024 as compared to Rs. 32.1926 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs. 2.6505 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. 1.1133 crores for the period ended September 30, 2024.
The company has reported EPS of Rs. 1.33 for the period ended December 31, 2024 as compared to Rs. 0.53 for the period ended September 30, 2024.
| Financials | Q3 FY2025 | Q2 FY2025 | % Change |
| Total Income | ₹ 36.8728 crs | ₹32.1926 crs |  14.54% |
| Net Profit | ₹2.6505 crs | ₹1.1133 crs | 138.08% |
| EPS | ₹1.33 | ₹0.53 | 150.94% |
Financial Results (Q3 FY2025) - YoY Comparison
The company has reported total income of Rs. 36.8728 crores during the period ended December 31, 2024 as compared to Rs.31.7376 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.2.6505 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.3.8195 crores for the period ended December 31, 2023.
The company has reported EPS of Rs.1.33 for the period ended December 31, 2024 as compared to Rs.2.02 for the period ended December 31, 2023.
| Financials | Q3 FY2025 | Q3 FY2024 | % Change |
| Total Income | ₹ 36.8728 crs | ₹31.7376 crs | 16.18% |
| Net Profit | ₹2.6505 crs | ₹3.8195 crs |  -30.61% |
| EPS | ₹1.33 | ₹2.02 | -34.16% |
Financial Results (9 Months Ended FY2025) - YoY Comparison
The company has reported total income of Rs.312.9405 crores during the 9 Months period ended December 31, 2024 as compared to Rs.289.5869 crores during the 9 Months period ended December 31, 2023.
The company has posted net profit / (loss) of Rs.37.1188 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.38.4998 crores for the 9 Months period ended December 31, 2023.
The company has reported EPS of Rs.19.35 for the 9 Months period ended December 31, 2024 as compared to Rs.20.29 for the 9 Months period ended December 31, 2023.
| Financials | 9 Months Ended FY2025 | 9 Months Ended FY2024 | % Change |
| Total Income | ₹312.9405 crs | ₹289.5869 crs | 8.06% |
| Net Profit | ₹37.1188 crs | ₹38.4998 crs | -3.59% |
| EPS | ₹19.35 | ₹20.29 | -4.63% |
Shares of Nath Bio-Genes (India) Limited was last trading in BSE at Rs. 176.45 as compared to the previous close of Rs. 177.55. The total number of shares traded during the day was 2740 in over 119 trades.
The stock hit an intraday high of Rs. 183.85 and intraday low of 175.30. The net turnover during the day was Rs. 485469.00.
